loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 213413 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Leading Pharma, LLC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE (1)

    filter

    01 LEADING (1)

    filter

    01 TABLET;ORAL (1)

    filter

    01 0.025MG;2.5MG (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Atropine Sulfate; Diphenoxylate Hydrochloride

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET;ORAL
    0.025MG;2.5MG
    DIPHENOXYLATE HYDROCHL...
    USA
    213413
    2020-02-20
    RX
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 213413

    Looking for CTD TGA MCC DOSSIER APPLICATION 213413 1

    19

    Leading Pharma, LLC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their notable products is ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE, with a corresponding application number 213413 and regulatory information .

    proudly manufactured in the

    approval since 2020-02-20

    Leading Pharma, LLC's DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE TABLET;ORAL, medication with 0.025MG;2.5MG of ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE.

    Post Enquiry
    POST ENQUIRY